Neuronetics (STIM) Gains from Sales and Divestitures (2016 - 2026)

Neuronetics (STIM) has 11 years of Gains from Sales and Divestitures data on file, last reported at $774000.0 in Q1 2026.

• Gains from Sales and Divestitures for Q1 2026 came in at $774000.0, down 19.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $774000.0 (down 19.96% YoY), and the FY2025 annual result was $1.6 million, up 8.33% from the prior year.
• Gains from Sales and Divestitures fell to $774000.0 in Q1 2026 per STIM's latest filing, from $1.6 million in the prior quarter.
• Over five years, Gains from Sales and Divestitures peaked at $1.8 million in Q4 2023 and troughed at $318000.0 in Q1 2022.
• A 5-year average of $1.1 million and a median of $1.2 million in 2024 frame the typical range for Gains from Sales and Divestitures.
• The sharpest annual moves came in 2023 and 2024: Gains from Sales and Divestitures jumped 277.75% in 2023, then declined 26.23% in 2024.
• A 5-year view of Gains from Sales and Divestitures shows it stood at $705000.0 in 2022, then surged by 158.58% to $1.8 million in 2023, then slipped by 19.69% to $1.5 million in 2024, then advanced by 8.33% to $1.6 million in 2025, then sank by 51.2% to $774000.0 in 2026.
• Business Quant data shows STIM's Gains from Sales and Divestitures at $774000.0 in Q1 2026, $1.6 million in Q4 2025, and $1.3 million in Q3 2025.